Listed by the USPTO as FETTEROLF, BRANDON J
Tech Center 1600 • Art Units: 1622 1626 1628 1629 1642
This examiner grants 52% of resolved cases
FETTEROLF, BRANDON J has 225 resolved cases in Tech Center 1600 and art unit 1622. The allowance rate is 51.6%, the interview lift is 18.5%, and the median time to allowance is 1300 days. The record indicates a moderate allowance outcome and an extended median timeline, with interviews providing a useful but not dominant measured effect.
The listed companies are THE GENERAL HOSPITAL Corporation, Astrazeneca AB, and Taiho Pharmaceutical Co., Ltd. The listed firms are OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P., Abel Schillinger, LLP, and Apex Attorneys at Law, LLP. Practitioners should plan for continued prosecution, prepare focused interview topics, and maintain clear written support for amendments addressing the cited art.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18033724 | COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS | Non-Final OA | MERCK PATENT GMBH |
| 18716645 | METHOD FOR PRODUCING ISOXAZOLINECARBOXYLIC ACID DERIVATIVES | Non-Final OA | BAYER AKTIENGESELLSCHAFT |
| 18035346 | USE OF DIHYDROMYRICETIN AS EPIGENETIC ACTIVE INGREDIENT FOR COSMETIC OR DERMATOLOGICAL SKIN CARE | Non-Final OA | BEIERSDORF AG |
| 18849729 | INJECTABLE PREPARATION COMPRISING ISOXAZOLINE DERIVATIVE, AND PREPARATION METHOD THEREFOR | Non-Final OA | LG CHEM, LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy51.6% of resolved applications examined by Brandon J Fetterolf were allowed (225 resolved cases), compared with 60.6% across Art Unit 1622 over the last five years.
This examiner's interview lift is +18.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Brandon J Fetterolf took 1,300 days on average from filing to allowance.
Brandon J Fetterolf examines applications in Art Unit 1622 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
